4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-22-000007
Options or other derivatives
- Director acquired 72,872 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mahatme Ujwala · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 1 in the form Stock Option (right to buy) | +25,000 | 25,000 | D | ||
| 2022-01-03 | Grant or award : show line 2 in the form Stock Option (right to buy) | +47,872 | $1.13 | $54,095 | 72,872 | D |
Loading xslF345X03/wf-form4_164141670774490.xml…